All Articles

Polaris's new virtual clinic promises sleep apnea diagnosis in under a week, using at-home tests and telehealth to bypass traditional lab delays.

With a history of beating expectations and a new acquisition in tow, all eyes are on Calian's Q3 results to see if its mission-critical strategy can sustain momentum.

With backing from Galaxy, Coinbase, and Franklin Templeton, Soter Insure is building the risk management infrastructure that could finally bring Wall Street to crypto.

A new $250M deal from Crayhill Capital isn't just funding; it's a strategic weapon for navigating grid bottlenecks and meeting soaring energy demand.

As employees drown in a sea of apps, Appspace is betting that a single, intelligent platform is the key to a productive and connected workplace.

With 7M+ virtual home energy assessments done since 2023, Canada lacked a shared standard. Now, Climative is helping set the bar for accuracy and trust.

With a novel drug targeting an unaddressed cause of glaucoma, Qlaris Bio adds a seasoned expert to its board, signaling a pivotal push toward market entry.

New benchmarks show EDB Postgres AI outperforming rivals, challenging the architectural status quo and arguing that a unified data foundation is the future.

As hospitals acquire private practices at a record pace, a new platform offers independent physicians the same data-driven edge to survive and thrive.

A new class of disposable devices makes a common surgery four times faster and five times less bloody. So why is this Asia-led innovation invisible to US regulators?

Jewelry firm 25karats has launched a free online tool providing real-time melt values for gold, silver, and platinum to empower consumers.

Uber Eats is adding regional grocers to its platform, a move that goes beyond convenience to challenge Instacart and DoorDash in the $250B online grocery war.

A former nuclear site in Kentucky is the seed for a $100B AI hub, promising jobs and a new energy model. But can it overcome a toxic legacy and truly protect ratepayers?

Despite a sales slump, Monro's strategic cost cuts and operational overhaul are driving a surprising profit recovery. Is this the start of a lasting turnaround?

Processa Pharmaceuticals acquires Vidya Therapeutics and its key asset, VT-7208, backed by a $200M financing that radically overhauls the company's strategy.

After a stellar Q1 and credit upgrade, all eyes are on Alliance Laundry's upcoming earnings. We dissect the trends and strategies that will define its success.

Qnovia secures a license for a novel peptide, D8, that kills superbugs differently. Can this university-born innovation turn the tide on antibiotic resistance?

A new government partnership with AI firm Quantifind signals a tectonic shift in how the U.S. protects its vital communications from hidden foreign threats.

Rabobank North America's appointment of a 20-year tech veteran as COO signals a major shift, prioritizing digital resilience to fortify its critical food and energy financing.